(Q70417874)
Statements
A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study (English)
Pannuti F
Iafelice G
Martoni A
Fruet F
Angelelli B